Cover Image

COVID-19 infection: disease mechanism, vascular dysfunction, immune responses, markers, multiorgan failure, treatments, and vaccination

Saved in:

Bibliographic Details
Date:	2020
Main Author:	S. G. Vari
Format:	Article
Language:	English
Published:	2020
Series:	The Ukrainian Biochemical Journal
Online Access:	http://jnas.nbuv.gov.ua/article/UJRN-0001347057
Tags:	Add Tag No Tags, Be the first to tag this record!
Journal Title:	Library portal of National Academy of Sciences of Ukraine \| LibNAS

Institution

Library portal of National Academy of Sciences of Ukraine | LibNAS

Similar Items

Action of booster immunization with E2 CSFV on immune response elicited by marker DNA-vaccine against CSF
by: Pokholenko, Ia.O., et al.
Published: (2012)

Action of booster immunization with E2 CSFV on immune response elicited by marker DNA-vaccine against CSF
by: Ia. O. Pokholenko, et al.
Published: (2012)

Budget capacite of Ukraine for financing of COVID-19 vaccination in the emerging global vaccine market
by: V. M. Heiets, et al.
Published: (2021)

Prognosis of RNA, siRNA, Followed by the Immunological Response of the Proposed Vaccine (Vac534) against COVID-19
by: Dawood, A.A., et al.
Published: (2024)

Modeling of the COVID-19 pandemic in the limit of no acquired immunity
by: J. M. Ilnytskyi
Published: (2021)

Determination of groups of risks at the diseases COVID-19
by: A. A. Vagis, et al.
Published: (2021)

Determination of Groups of Risks at the Diseases COVID-19
by: O. A. Vahis, et al.
Published: (2020)

CORRECTION OF SHIVERING HYPERKINESIS IN PATIENTS WITH VEGETATIVE AND VASCULAR DYSFUNCTIONS
by: A. N. Stojanov, et al.
Published: (2016)

Plasma apolipoproteins A1/B and oxLDL levels in patients with COVID-19 as possible markers of the disease
by: V. V. Pushkarov, et al.
Published: (2021)

Molecular Characteristics of Blood Serum After Covid-19 Vaccination in a Remote Period
by: Pedachenko, Y.E., et al.
Published: (2024)

Optimal control strategy for the administration of the third vaccine dose in the treatment of pandemic COVID-19
by: I. Khaloufi, et al.
Published: (2023)

The types of immune response in different forms of Epstein - Barr virus infection
by: T. I. Ljadova, et al.
Published: (2017)

Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
by: M. D. Tronko, et al.
Published: (2021)

Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
by: Tronko, M.D., et al.
Published: (2021)

Immune dysfunctions in patients with liver cyrrhosis with portal hypertension
by: O. F. Dzyhal, et al.
Published: (2017)

Coronavirus S antigen as a marker of effective vaccination
by: V. H. Spyrydonov, et al.
Published: (2021)

Clinic and complications of COVID-19 coronavirus disease with pathogenesis elements
by: V. P. Malyi, et al.
Published: (2020)

COVID-19: New disease and chaos with panic, associated with stres
by: S. Szabo
Published: (2020)

The legal basis for the compulsory vaccination of higher education institutions&#039; staff in the COVID-19 pandemic
by: N. S. Khatniuk, et al.
Published: (2022)

Conjugation of new DNA vaccine with polyethylenimine induces cellular immune response and tumor regression in neuroblastoma mouse model
by: Stegantseva, M.V., et al.
Published: (2023)

Variants of uric acid metabolism and their immune and microbiota accompaniment in patients with neuroendocrine-immune complex dysfunction
by: V. S. Smagliy, et al.
Published: (2020)

Evaluation of Interleukins and Biochemical Markers Levels Among COVID-19 Iraqi Patients
by: Al-Jubury, Kutaiba Sattar, et al.
Published: (2025)

Determination of the dependence between climatic factors and Covid-19 disease incidence
by: Mitryasova, Olena P., et al.
Published: (2021)

Determination of the dependence between climatic factors and Covid-19 disease incidence
by: O. P. Mitriasova, et al.
Published: (2021)

Characterization of vaccine and field IBDV strains in Ukraine for proper vaccine selection for disease prevention
by: Pastyria, A.S., et al.
Published: (2018)

The changes in the level of cytokines, glomerotubular markers, cardiohemodynamics in chronic heart failure and its combination with kidney disease
by: P. G. Kravchun, et al.
Published: (2012)

Study of the coronavirus SARS-CoV-2 and the COVID-19 disease caused by it
by: S. V. Komisarenko
Published: (2021)

The coronavirus disease COVID-19&#039;s coverage in Ukrainian and European encyclopedias
by: M. H. Zhelezniak, et al.
Published: (2020)

Correction of hyperglycemia, a predictor of endothelial dysfunction in petients with chronic heart failure
by: S. A. Krapivko, et al.
Published: (2017)

The features of immune regulation in patients with HCV infection
by: O. V. Gololobova
Published: (2015)

Diagnostic and practical significance of some markers of endothelism dysfunction in A influenza
by: A. I. Vereshchagina
Published: (2018)

Endothelium and endothelial dysfunction - health implications and risk for cardiovascular diseases
by: Rutowski, J.A., et al.
Published: (2012)

The virtual screening application for searching potential antiviral agents to treat COVID-19 disease
by: L. V. Yevsieieva, et al.
Published: (2020)

On the participation of scientists of the NAS of Ukraine in counteracting COVID-19. Development of vaccines against SARS-CoV-2 and COVID-19 in Ukraine: Status, problems and prospects (transcript of report at the meeting of the Presidium of NAS of Ukraine,
by: S. V. Komisarenko
Published: (2021)

Influence of hepatitis A in the period of recoveryon maintaining post-vaccination immunity to diphtheria
by: A. S. Podorozhnaja, et al.
Published: (2013)

Fractional HCV infection model with adaptive immunity and treatment
by: Z. Yaagoub, et al.
Published: (2023)

Immunoglobulin isotypes and blood monocyte subpopulations in COVID-19 female patients with different disease severity
by: K. Rebenko, et al.
Published: (2022)

Apolipoprotein B and oxLDL levels in plasma of patients with diabetes, cardiovascular disease, and COVID-19
by: Tronko, M.D., et al.
Published: (2021)

Influence of introduction of interleukin-2 and interleukin-12 into experimental marker DNA-vaccine
by: Ya. O. Pokholenko, et al.
Published: (2019)

Challenges of the COVID-19 pandemic to pharmaceutical manufacturing: the EU and Ukraine&#039;s response
by: O. B. Salikhova, et al.
Published: (2021)